Effects of liquiritigenin treatment on the learning and memory deficits induced by amyloid β-peptide (25-35) in rats

Behavioural Brain Research

Volumn 210, Issue 1, 2010, Pages 24-31

  Liu, Rui Ting ^b   Zou, Li Bo ^b   Fu, Jie Ying ^b   Lu, Qiu Jun ^a  

^a Genova Beijing Biopharmaceutical Research Institute   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Amyloid peptide; Behavior; Cognition; Estrogen receptor ; Liquiritigenin; Notch 2

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; LIQUIRITIGENIN; MESSENGER RNA; NOTCH2 RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HIPPOCAMPUS; LEARNING DISORDER; MALE; MEMORY DISORDER; NERVE CELL DEGENERATION; NERVE REGENERATION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RISK REDUCTION;

AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; CELL COUNT; ESTROGEN RECEPTOR BETA; FEMALE; FLAVANONES; LEARNING DISORDERS; MALE; MEMORY DISORDERS; NEURONS; NEUROPSYCHOLOGICAL TESTS; NOOTROPIC AGENTS; PEPTIDE FRAGMENTS; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECEPTOR, NOTCH2; RNA, MESSENGER; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 77949567251     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.01.041     Document Type: Article

References (44)

1. Alkam T., Nitta A., Mizoguchi H., Saito K., Seshima M., Itoh A., et al. Restraining tumor necrosis factor-alpha by thalidomide prevents the amyloid β-induced impairment of recognition memory in mice. Behav Brain Res 2008, 189:100-106.
2. Artavanis-Tsakonas S., Matsuno K., Fortini M.E. Notch signaling. Science 1995, 268:225-232.
3. Artavanis-Tsakonas S., Rand M.D., Lake R.J. Notch signaling: cell fate control and signal integration in development. Science 1999, 284:770-776.
4. Bang O.Y., Hong H.S., Kim H.D., Kim H., Boo J.H., Huh K., et al. Neuroprotective effect of genistein against beta amyloidinduced neurotoxicity. Neurobiol Dis 2004, 16:21-28.
5. Bowe W.B., Blalock E.M., Chen K.C., Kadish I., Wang D., Barrett J.E., et al. Hippocampal expression analyses reveal selective association of immediate-early, neuroenergetic, and myelinogenic pathways with cognitive impairment in aged rats. J Neurosci 2007, 27:3098-3110.
6. Brann D.W., Dhandapani K., Wakake C., Mahesh V.B., Khan M.M. Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications. Steroids 2007, 72:381-405.
7. Carroll J.C., Pike C.J. Selective estrogen receptor modulators differentially regulate Alzheimer-like changes in female 3xTg-AD mice. Endocrinology 2008, 149:2607-2611.
8. Frick K.M. Estrogens and age-related memory decline in rodents: what have we learned and where do we go from here?. Horm Behav 2009, 55:2-23.
9. Gustafsson J.A. What pharmacologists can learn from recent advances in estrogen signaling. Trends Pharmacol Sci 2003, 24:479-485.
10. Hammond R., Mauka R., Ninacia D., Nelsona D., Gibbs R.B. Chronic treatment with estrogen receptor agonists restores acquisition of a spatial learning task in young ovariectomized rats. Horm Behav 2009, 56:309-314.
11. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
12. Hewitt S.C., Korach K.S. Oestrogen receptor knockout mice: roles for oestrogen receptors alpha and beta in reproductive tissues. Reproduction 2003, 125:143-149.
13. Hummon A.B., Lim S.R., Difilippantonio M.J., Ried T. Isolation and solubilization of proteins after TRIzol extraction of RNA and DNA from patient material following prolonged storage. Biotechniques 2007, 42:467-472.
14. James W., Simpkins M.S. More than a decade of estrogen neuroprotection. Alzheimers Dement 2008, 4(Suppl. 1):S131-S136.
15. Kang H.E., Jung H.Y., Cho Y.K., Kim S.H., Sohn S.I., Baek S.R., et al. Pharmacokinetics of liquiritigenin in mice, rats, rabbits, and dogs, and animal scale-up. J Pharm Sci 2009, [Epub ahead of print].
16. Kim S.C., Byun S.H., Yang C.H., Kim C.Y., Kim J.W., Kim S.G. Cytoprotective effects of Glycyrrhizae radix extract and its active component liquiritigenin against cadmium-induced toxicity (effects on bad translocation and cytochrome c-mediated PARP cleavage). Toxicology 2004, 197:239-251.
17. Kim Y.W., Ki S.H., Lee S.J., Lee S.J., Kim C.W., Kim S.C., et al. Liquiritigenin, an aglycone of liquiritin in Glycyrrhizae radix, prevents acute liver injuries in rats induced by acetaminophen with or without buthionine sulfoximine. Chem Biol Interact 2006, 161:125-138.
18. Kim Y.W., Zhao R.J., Park S.J., Lee J.R., Cho I.J., Yang C.H., et al. Anti-inflamatory effects of liquiritigenin as a consequence of the inhibition of NF-κB-dependent iNOS and proinflammatory cytokines production. Br J Pharmacol 2008, 154:165-173.
19. Kubo T., Nishimura S., Kumagae Y., Kaneko I. In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients. J Neurosci Res 2002, 70:474-483.
20. Kupfer R., Swanson L., Chow S., Staub R.E., Zhang Y.L., Cohen I., et al. Oxidative in vitro metabolism of liquiritigenin, a bioactive compound isolated from the Chinese herbal selective estrogen beta-receptor agonist MF101. Drug Metab Dispos 2008, 36:2261-2269.
21. Liu F., Day M., Muñiz L.C., Bitran D., Arias R., Revilla-Sanchez R., et al. Activiation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory. Nat Neurosci 2008, 11:334-343.
22. Liu R.T., Zou L.B., Lu Q.J. Liquiritigenin inhibits β-amyloid peptide-induced neurotoxicity and the secretion of the peptide in rat hippocampal neurons. Acta Pharmacol Sin 2009, 30:899-906.
23. Artavanis-Tsakonas L.A. Notch signaling in vertebrate neural development. Nat Rev Neurosci 2006, 7:93-102.
24. Mehra R.D., Sharma K., Nyakas C., Vij U. Estrogen receptor alpha and beta immunoreactive neurons in normal adult and aged female rat hippocampus: a qualitative and quantitative study. Brain Res Brain Res Rev 2005, 1056:22-35.
25. Mersereau J.E., Levy N., Staub R.E., Baggett S., Zogric T., Chow S., et al. Liquiritigenin is a plant-derived highly selective estrogen receptor beta agonist. Mol Cel Endocrinol 2008, 283:49-57.
26. Mitra S.W., Hoskin E., Yudkovitz J., Pear L., Wilkinson H.A., Hayashi S., et al. Immunolocalization of estrogen receptor beta in the mouse brain: comparison with estrogen receptor alpha. Endocrinology 2003, 144:2055-2067.
27. Morrison S.J., Perez S.E., Qiao Z., Verdi J.M., Hicks C., Weinmaster G., et al. Transient notch activation initiates an irreversible switch from neurogenesis to gliogenesis by neural crest stem cells. Cell 2000, 101:499-510.
28. Pike C.J., Walencewicz-Wasserman A.J., Kosmoski J., Cribbs D.H., Glabe C.G., Cotman C.W. Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity. J Neurochem 1995, 64:253-265.
29. Purow B. Notch inhibitors as a new tool in the war on cancer: a pathway to watch. Curr Pharm Biotechnol 2009, 10:154-160.
30. Rizzo P., Miao H., D'Souza G., Osipo C., Yun J., Zhao H. Cross-talk between Notch and the estrogen receptor in breast cancer suggest novel therapeutic approaches. Cancer Res 2008, 68:5226-5235.
31. Selkoe D., Kopan R. Notch and presenilin: regulated intramembrane proteolysis links development and degeneration. Annu Rev Neurosci 2003, 26:565-597.
32. Shughrue P.J., Lane M.V., Merchenthaler I. Comparative distribution of estrogen receptor alpha and -beta mRNA in the rat central nervous system. J Comp Neurol 1997, 388:507-525.
33. Stepanichev M., Zdobnova I.M., Zarubenko I.I., Moiseeva Y.V., Lazareva N.A., Onufriev M.V., et al. Amyloid-beta (25-35)-induced memory impairments correlate with cell loss in rat hippocampus. Physiol Behav 2004, 80:647-655.
34. Stepanichev M.Y., Lazareva N.A., Onufriev M.V., Mitrokhina O.S., Moiseeva Y.V., Gulyaeva N.V., et al. The effect of the administration of beta-amyloid peptide fragment (25-35) on behavior in rats. Neurosci Behav Physiol 1998, 28:564-566.
35. Strooper B.D., Annaert W., Cupers P., Saftig P., Craessaerts K., Mumm J.S., et al. A presenilin-1dependent γ-secretase-like protease mediates release of Notch intracellular domain. Nature 1999, 398:518-522.
36. Tran M.H., Yamada K., Olariu A., Mizuno M., Ren X.H., Nabeshima T. Amyloid beta-peptide induces nitric oxide production in rat hippocampus: association with cholinergic dysfunction and amelioration by inducible nitric oxide synthase inhibitors. FASEB J 2001, 15:1407-1409.
37. Walf A.A., Koonce C., Frye C.A. Estradiol or diarylpropionitrile administration to wild type, but not estrogen receptor beta knockout, mice enhances performangce in the object recogition and object placement task. Neurobiol Learn Mem 2008, 89:513-521.
38. Walf A.A., Koonce C., Manley K., Frye C.A. Proestrous compared to diestrous wildtype, but not estrogen receptor beta knockout, mice have better performance in the spontaneous alternation and object recognition tasks and reduced anxiety-like behavior in the elevated plus and mirror maze. Behav Brain Res 2009, 196:254-260.
39. Warren M. A comparative review of the risks and benefits of hormone replacement therapy regimens. Am J Obstet Gynecol 2004, 190:1141-1167.
40. West M.J., Gundersen H.J. Unbiased stereological estimation of the number of neurons in the human hippocampus. J Comp Neurol 1990, 296:1-22.
41. Zameer A., Schulz P., Wang M.S., Sierks M.R. Single chain Fv antibodies against the 25-35 Abeta fragment inhibit aggregation and toxicity of Abeta42. Biochemistry 2006, 45:11532-11539.
42. Zhang L., Yu H.X., Sun Y., Lin X., Chen B., Tan C., et al. Protective effects of salidroside on hydrogen peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells. Eur J Pharmacol 2007, 564:18-25.
43. Zhao L., Neill K., Brinton D. Selective estrogen receptor modulators (SERMs) for the brain: current status and remaining challenges for developing neuroSERMs. Brain Res Brain Res Rev 2005, 49:472-493.
44. Zhao L.Q., Chen S.H., Brinton R.D. Neuroprotective and neurotrophic efficacy of phytoestrogens in cultured hippocampal neurons. Exp Biol Med 2002, 227:509-519.